Q3 report due Thursday, 16 November at 07:00 CET '23e-'25e EBITA down 0-3% 10-8x EBITA '23e-'25e, 12...
Order intake likely to start stabilising Healthy balance sheet helpful to gain market share '23e-'25...
'23e-'25e sales cut by 1-5% B2C volume recovery likely to take longer than expected EV/ARR 1.
Few order announcements put some risk on Q3e sales.
Q3 report due on Friday, 27 October Data centres strong, FTTH outlook muted Trading at 11x '23e EV/E...
Redeye is positive about ISAB’s new order worth EUR188,900 from a global generics manufacturer.
Eniro released a preliminary profit announcement; its revenue will come in at SEK 238m with an EBITD...
ChromoGenics announced last night that thay received an order of SEK5m for ConverLight dynamic glass...
Our site visit to KebNi's new production facility in Karlskoga not only showed production up and run...
Redeye takes a positive stance regarding Kontigo Care’s proposed directed share issue of approximate...
Down cycle continues; Q3e sales SEK 878m, adj. EBITDA SEK 17m Significant estimate revisions followi...
Reser betydande kapital Egetis meddelade under tisdagskvällen att de reser 462 mkr, varav 172 mkr ge...
Escalating peer comments on GLP-1 obesity drugs No comment yet from Nolato, but there are some clues...
On 12 October, Fiskars lowered its adjusted EBIT guidance for 2023 from EUR 120-130m to EUR 100-120m...
No announced orders in Q3 puts some risk on order intake.
11% CAGR in net profit for 2022-25e... ...and 10-11% dividend yield p.
Hansa has provided a clinical update and top-line results ahead of the Q3 results.
Fiskars lowers its guidance for 2023 and published preliminary information of Q3.
Ett av branschens starkaste tillväxtbolag med ett transformativt förvärv till låg värdering Sun4Ener...
Bivoca has signed a direct bill contract providing access to DiviTum TKa to appropriate patients tre...
